GlassScriptPhysician profile
Brandon David Hecht
NPI 1578827713
$2,215.72
in general payments reported to CMS, 2019-2025
31 companies · $1,024 in 2025
The $1,024 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $119 · 2023: $415 · 2024: $659 · 2025: $1,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,097.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,096.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $312.15 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $235.46 | 2023-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $217.16 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Dexcom, INC. | $209.94 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Pfizer INC. | $169.17 | 2023-2025 | |
| Abbott Laboratories | $155.86 | 2025 | Freestyle Libre 3 |
| Abbvie INC. | $112.61 | 2023-2025 | |
| Glaxosmithkline, LLC. | $108.15 | 2022-2025 | Shingrix, Arexvy, Bexsero |
| Amgen INC. | $73.96 | 2023-2024 | Repatha, Otezla |
| Edwards Lifesciences Corporation | $62.72 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Astellas Pharma US INC | $62.33 | 2024-2025 | Veozah |
| Exact Sciences Corporation | $60.64 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Eisai INC. | $38.64 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.30 | 2024-2025 | Xifaxan |
| Inari Medical, INC. | $31.98 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $28.51 | 2022 | |
| Acadia Pharmaceuticals INC | $27.48 | 2025 | Nuplazid |
| Daiichi Sankyo INC. | $23.21 | 2022 | |
| Merck Sharp & Dohme LLC | $22.88 | 2023 | Keytruda, Lynparza |
| Sanofi-Aventis U.S. LLC | $22.79 | 2024 | |
| Cipher Pharmaceuticals US LLC | $22.47 | 2025 | Natroba, Spinosad |
| Janssen Biotech, INC. | $22.35 | 2023 | Erleada |
| Radius Health, INC. | $20.72 | 2025 | Tymlos |
| Seagen INC. | $20.51 | 2023 | Tukysa |
| Actelion Pharmaceuticals US, INC. | $20.30 | 2024 | Uptravi, Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $19.69 | 2023 | |
| Morphosys, US INC. | $16.59 | 2022 | |
| Esperion Therapeutics, INC. | $16.38 | 2025 | Nexletol |
| Alexion Pharmaceuticals, INC. | $16.31 | 2023 | Ultomiris |
| Incyte Corporation | $15.73 | 2023 | Monjuvi, Pemazyre |
| Sobi, INC | $13.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Hecht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.